U.S. District Judge John Keenan has told the jury in the Merck Fosamax lawsuit case in New York to keep deliberating, despite the panel's claim that it can't reach a decision, according to a story on Bloomberg.com.
The jury is trying to decide whether Merck's bisphosonate drug, used to treat osteoporosis, caused a Florida woman to develop osteonecrosis of the jaw.
The trial is the first of three so-called bellwether trials that could pave the way for out-of-court settlements in some 900 related Fosamax complaints.
In related news, Judge Keenan rejected Merck's effort to dismiss 24 of the pending Fosamax cases, according to news reports.
Copyright © 2009 DrBicuspid.com
